Paradox of possibilities: the rare landscape in the Asia Pacific Region

Author:

Jain RituORCID,Wang Chiuhui Mary,Foster Lisa,Li Eileen Yangyang,Nishimura Yukiko,Tsang Kin Ping

Abstract

The Asia-Pacific (APAC) region, home to 60% of the global population, has the highest number of Persons Living with a rare disease (PLWRD). To promote more equitable societies, the Asia Pacific rare disease Organization (APARDO), established in 2015, has been developing its regional position to promote collaboration, increase awareness among stakeholders, explore equitable and affordable diagnosis and treatment, and improve health outcomes and quality of life for all PLWRD. The APAC region’s heterogeneous population and complex healthcare environment pose distinctive challenges in addressing rare diseases. Through conferences, webinars, and contributions to global initiatives, APARDO is fostering connectivity and providing a platform as a part of the global rare disease (RD) community to address shared challenges. The development of APARDO to strengthen its global presence as the representative of the APAC RD region is vital for a more equitable world.

Publisher

OAE Publishing Inc.

Reference66 articles.

1. Asia Population 2023. n.d. Available from: https://worldpopulationreview.com/continents/asia-population [Last accessed on 28 Feb 2024].

2. News & insights. Rare disease care across Asia Pacific. 2023. Available from: https://sandpipercomms.com/health/rare-disease-care-across-asia-pacific/ [Last accessed on 28 Feb 2024].

3. Jain R. Rare diseases in Asia and the Pacific must be tackled too. Asia Pathways. 2020. Available from: https://www.asiapathways-adbi.org/2020/07/rare-diseases-asia-pacific-must-be-tackled-too/ [Last accessed on 28 Feb 2024].

4. The Economist Intelligence Unit. Suffering in silence: assessing rare disease awareness and management in Asia-Pacific. 2020. Available from: https://www.cslbehring.com.au/-/media/shared/economist-white-paper/eng_white-paper_a4_digital_final.pdf [Last accessed on 28 Feb 2024].

5. Correction: Rare disease in Malaysia: Challenges and solutions

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3